NewsBite

Supermarkets are selling more eggs. Gyms are getting rid of cardio machines to make more room for free weights. And cosmetic clinics are seeing a lot of “Ozempic face”. It’s estimated about 9 per cent of Americans are on the new breed of weight loss drugs known as GLP-1s. While we don’t yet know how many Australians are taking the jab, we’re certainly seeing the effects.

Loading...
Euan Black is a work and careers reporter at The Australian Financial Review. Email Euan at euan.black@afr.com
Eugenie Kelly writes on fashion, interiors, the arts, style and travel, and edits Life & Leisure's Spend pages. She was previously editor-in-chief of Harper’s Bazaar Australia.
Lauren Sams is the fashion editor, based in Sydney. She writes about lifestyle including the arts, entertainment, fashion and travel. Lauren has worked as a features editor and fashion journalist for ELLE, marie claire and more. Email Lauren at lauren.sams@afr.com
Matthew Drummond edits AFR Magazine, our premium monthly inserted magazine that covers business, politics, fashion, design, food and wine, and is home to the Rich List, Young Rich List and the Power lists. Connect with Matthew on Twitter. Email Matthew at matthew.drummond@afr.com.au
Maxim Boon is production editor, Life & Leisure, at the Financial Review.
Michael Smith is the health editor for The Australian Financial Review. He is based in Sydney. Connect with Michael on Twitter. Email Michael at michael.smith@afr.com
Rachael Bolton is Social Media Editor for The Australian Financial Review. Connect with Rachael on Twitter. Email Rachael at rachael.bolton@afr.com.au
Sam Bennett is art director of The Australian Financial Review Magazine. Email Sam at sam.bennett@afr.com.au

Read More

Latest In Healthcare & fitness

Fetching latest articles

Most Viewed In Companies

    Original URL: https://www.afr.com/companies/healthcare-and-fitness/how-ozempic-and-other-glp-1s-are-transforming-much-more-than-just-waistlines-20250320-p5ll8i